pocketful logo
Quick Heal Technologies Ltd logo

Quick Heal Technologies Ltd

NSE: QUICKHEAL BSE: 539678

₹166.37

(0.45%)

Sun, 01 Mar 2026, 02:54 pm

Quick Heal Technologies EV/EBITDA Ratio

Particulars20112012201320142015201620172018201920202021202220232024
Price to earnings ratio000023.4531.3322.5317.337.1611.2112.74116.74104.96313.70
Price to book ratio00002.422.512.582.020.811.591.641.685.763.51
Price to sales ratio00004.505.565.875.051.863.603.102.698.725.66
Price to cash flow ratio000016.3827.9016.5118.086.1311.2412.7222.87131.960
Enterprise value00009.78B12.82B14.18B10.97B1.78B7.31B7.07B5.59B23.24B13.88B
Enterprise value to EBITDA ratio00009.4913.9111.088.461.905.076.46114.09117.130
Debt to equity ratio00000000000000
Return on equity %031.0518.9116.2112.058.3911.9812.1310.3815.3312.061.225.661.15

Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio

The Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Quick Heal Technologies Ltd's valuation, profitability, and overall financial performance. Tracking the Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Quick Heal Technologies Ltd (NSE: QUICKHEAL, BSE: 539678) is currently trading at ₹166.37, with a market capitalization of ₹9B. As a leading company in the Technology services sector and Packaged software industry, monitoring the Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio Current Value

The current Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio stands at 0.

The Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

  • 2024: 0
  • 2023: 117.13
  • 2022: 114.09
  • 2021: 6.46
  • 2020: 5.07

The decline in Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.

What Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Quick Heal Technologies Ltd.

Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Quick Heal Technologies Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800